Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $38.9B |
| FY2017, ended Dec 31, 2017 | $40.5B |
| FY2018, ended Dec 31, 2018 | $40.8B |
| FY2019, ended Dec 31, 2019 | $41.3B |
| FY2020, ended Dec 31, 2020 | $51.8B |
| FY2021, ended Dec 31, 2021 | $68.5B |
| FY2022, ended Dec 31, 2022 | $78.9B |
| FY2023, ended Dec 31, 2023 | $96.4B |
| FY2024, ended Dec 31, 2024 | $77.9B |
| FY2025, ended Dec 31, 2025 | $81.6B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $64.2B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $4.86B |
| FY2017, ended Dec 31, 2017 | $5.87B |
| FY2018, ended Dec 31, 2018 | $5.15B |
| FY2019, ended Dec 31, 2019 | $6.56B |
| FY2020, ended Dec 31, 2020 | $8.50B |
| FY2021, ended Dec 31, 2021 | $16.1B |
| FY2022, ended Dec 31, 2022 | $12.2B |
| FY2023, ended Dec 31, 2023 | $13.1B |
| FY2024, ended Dec 31, 2024 | $14.2B |
| FY2025, ended Dec 31, 2025 | $14.3B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $15.5B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $896M | $974M |
| FY2017, ended Dec 31, 2017 | $1.20B | $1.03B |
| FY2018, ended Dec 31, 2018 | $2.44B | $1.81B |
| FY2019, ended Dec 31, 2019 | $2.12B | $2.00B |
| FY2020, ended Dec 31, 2020 | $3.51B | $2.00B |
| FY2021, ended Dec 31, 2021 | $8.08B | $6.53B |
| FY2022, ended Dec 31, 2022 | $4.34B | $4.42B |
| FY2023, ended Dec 31, 2023 | $3.95B | $3.88B |
| FY2024, ended Dec 31, 2024 | $4.41B | $3.66B |
| FY2025, ended Dec 31, 2025 | $4.50B | $4.08B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $4.33B | $3.76B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $535M |
| FY2017, ended Dec 31, 2017 | $813M |
| FY2018, ended Dec 31, 2018 | $1.47B |
| FY2019, ended Dec 31, 2019 | $1.62B |
| FY2020, ended Dec 31, 2020 | $2.19B |
| FY2021, ended Dec 31, 2021 | $2.89B |
| FY2022, ended Dec 31, 2022 | $3.11B |
| FY2023, ended Dec 31, 2023 | $2.73B |
| FY2024, ended Dec 31, 2024 | $2.49B |
| FY2025, ended Dec 31, 2025 | $3.12B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $2.46B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | — |
| FY2017, ended Dec 31, 2017 | — |
| FY2018, ended Dec 31, 2018 | — |
| FY2019, ended Dec 31, 2019 | $0 |
| FY2020, ended Dec 31, 2020 | $1.98B |
| FY2021, ended Dec 31, 2021 | $1.98B |
| FY2022, ended Dec 31, 2022 | $1.98B |
| FY2023, ended Dec 31, 2023 | $1.98B |
| FY2024, ended Dec 31, 2024 | $1.98B |
| FY2025, ended Dec 31, 2025 | $1.99B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $1.99B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 2.9% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 106M |
| FY2017, ended Dec 31, 2017 | 108M |
| FY2018, ended Dec 31, 2018 | 109M |
| FY2019, ended Dec 31, 2019 | 110M |
| FY2020, ended Dec 31, 2020 | 107M |
| FY2021, ended Dec 31, 2021 | 109M |
| FY2022, ended Dec 31, 2022 | 109M |
| FY2023, ended Dec 31, 2023 | 110M |
| FY2024, ended Dec 31, 2024 | 109M |
| FY2025, ended Dec 31, 2025 | 106M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 103M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $0 | $560M | $127M |
| FY2017, ended Dec 31, 2017 | $0 | $507M | $240M |
| FY2018, ended Dec 31, 2018 | $4.40M | $427M | $115M |
| FY2019, ended Dec 31, 2019 | $276M | $464M | $212M |
| FY2020, ended Dec 31, 2020 | $5.85B | $432M | $2.58B |
| FY2021, ended Dec 31, 2021 | $1.65B | $602M | $1.67B |
| FY2022, ended Dec 31, 2022 | $2.08B | $725M | $1.52B |
| FY2023, ended Dec 31, 2023 | $2.23B | $885M | $1.15B |
| FY2024, ended Dec 31, 2024 | $2.60B | $983M | $1.47B |
| FY2025, ended Dec 31, 2025 | $3.44B | $994M | $636M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $3.30B | $987M | $756M |
Valuation
At current price- Market Cap
- $84.0B
- P/E
- 19.4×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 5.4×
- Price / Book
- 2.6×
- EV / EBITDA
- 19.1×
Growth
Trailing 12 months- Revenue (TTM)
- $15.5B
- Revenue Growth YoY
- 9.3%
- Revenue CAGR 3Y
- 5.6%
- Revenue CAGR 5Y
- 11.0%
- EPS Growth YoY
- 1.8%
- Net Income Growth YoY
- −2.9%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 24.7%
- Net Margin
- 27.9%
- FCF Margin
- 24.2%
- Return on Equity
- 14.0%
Earnings
Trailing 12 months- Net Income
- $4.33B
- EPS (diluted)
- $40.41
- EBITDA
- $4.37B
- Operating Income
- $3.84B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $2.46B
- Total Debt
- $1.99B
- Net Cash
- $469M
- Total Assets
- $41.7B
- Total Liabilities
- $10.0B
- Shareholders' Equity
- $31.7B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $4.68B
- Capital Expenditure
- $921M
- Free Cash Flow
- $3.76B
Dividends and risk
Last 12 months- Dividend Yield
- 0.5%
- Dividend / Share
- $3.70
- Beta (5Y)
- 0.16
Every ratio is calculated from the company’s reported figures.